Whitehawk Therapeutics, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $7.1 | $26.0 | $24.4 | $15.2 | $14.0 |
| Operating income | -$114.4 | -$67.5 | -$71.9 | -$62.7 | -$111.2 |
| Net income | -$20.6 | -$63.7 | -$65.8 | -$60.5 | -$110.1 |
| Cash Flow Statement | |||||
| Free cash flow | -$98.0 | -$61.2 | -$63.6 | -$50.1 | -$22.5 |
| Dividends | — | — | — | $0.0 | $4.4 |
Shares outstanding 49.5M · Free float 29.4%
Annual filing data through FY ended December 31, 2025; float as of August 29, 2026.